Hepatocellular Carcinoma — Trials

Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 693
Recruiting: 411
Ph III recruiting: 39
Growth YoY: +0.6%
Industry share: 23%
Top sponsor: Sun Yat-sen University
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (356)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06204835	ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery	recruiting	Phase 1	90	Institute of Automation, Chinese Academy of SciencesOTHER	1	May 22, 2024	clinicaltrials
NCT06363006	Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer	recruiting	Phase 1	40	Peking Union Medical College HospitalOTHER	1	Apr 12, 2024	clinicaltrials